The global stem cell banking market is experiencing robust compound annual growth rate (CAGR) expansion, driven by escalating demand-side dynamics, rising awareness of regenerative medicine ...

Researchers identified a six-gene signature in microscopic colorectal cancer (CRC) liver metastases that may help predict ...

A study tracking more than 10,000 patients with early-stage, obesity-related cancers found that those taking GLP-1 receptor ...

Patients with triple-negative breast cancer who cannot receive immunotherapy now have a new first-line treatment option after ...

The field of cancer genomics is rapidly evolving, driven by advanced technologies that enable detailed characterization of cancer initiation, progression, ...

Exelixis, Inc.'s STELLAR-303 zanzalintinib data disappoints in colorectal cancer with an FDA decision due in December 2026.

Scientists at USC have developed a way to create a renewable supply of immune cell precursors that can be grown in large ...

Researchers found that mRNA cancer vaccines can recruit an unexpected immune cell to launch powerful tumor-fighting responses ...

On 1 June 2026, the European Commission published a communication setting out a roadmap to phase out animal testing for ...

A team at Roswell Park Comprehensive Cancer Center has identified a novel metabolic pathway that plays a key role in enabling ...

Cellular senescence occupies a pivotal position in cancer biology, acting as both a barrier against malignant transformation and a potential driver of ...

Fate Therapeutics (FATE) pivots to autoimmune CAR T-cell therapies, with FT819 advancing toward a registrational lupus ...